Product Wiki · Recalls · Health Canada — Medical Devices

Atellica CH 930, IM 1300, and IM 1600 Analyzer (2018-09-30) — recall 58571

Health Canada — Medical Devices · Canada · 2018-10-19 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
58571
Date of alert
2018-10-19
Country / jurisdiction
Canada
Risk level
Type II
Risk type
recall
Product category
Medical devices
Product type
Medical devices
Reported risk: Siemens Healthcare Diagnostics has identified the following issues with the Atellica Solution, which are installed with Atellica Solution software (SW) versions 1.14.2 (SMN 11316393) or lower. Issue Number 1 - The cover interlocks on the Atellica Magline Transport for the Atellica CH 930 Analyzer, IM 1300 Analyzer, and IM 1600 Analyzer may not work as expected. When an Atellica Magline Transport cover in the front or back of an analyzer is opened, carrier motion may continue and the operator may not be alerted that a cover is open. Issue Number 2 - The Atellica IM 1300 Analyzer and IM 1600 Analyzer may use the T3/T4/VB12 Ancillary Reagent after expiration. The following scenarios may occur: T3 and T4 results generated using expired T3/T4/VB12 Ancillary Reagent are reported with a result flag, "OBS extended". VB12 dilution results generated with expired T3/T4/VB12 Ancillary Reagent are not reported with a flag. Issue Number 3 - The Atellica IM 1300 Analyzer and Atellica IM 1600 Analyzer may not calibrate T4. Intermittent failures may occur when calibrating the T4 assay due to observed errors in one or more replicates. The result in the Worklist will be flagged with a "Signal shape error". Issue Number 4 - The Atellica CH 930 may report incorrect serum indices for Hemolysis, Icterus and Lipemia (H, I, and L) for any test run on the patient sample. The CH analyzer generates H, I, and L serum indices in two ways. Method 1: If the Setup->Settings->General Setup->Patient->HIL Ordering option is set to "Alwaysorder" or "According to TDef", for samples with one or more of the following tests, ALT, AST, LDLP, and UN_c, the indices are calculated from one of these tests. Method 2: For samples without one of the tests listed in "Method 1" above, the indices are generated independently and are correct. The serum indices calculated when 'Method 1' is used may not be consistent with the sample or the independently derived H, I, and L indices using "Method 2".
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/atellica-ch-930-im-1300-and-im

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.